PreEmptive Meds launches unique nutraceutical formulation for immunity

29 January 2021 | News

Available in three different flavours, PreVID is a 100% vegan, sugar-free and gluten-free product

PreEmptive Meds, Inc., (PMEDS), a research-driven Over-The-Counter Therapeutics Company focused on pre-emptive care, has recently unveiled PreVID – a proprietary nutraceutical formulation developed by doctors to power up immunity in individuals who are at risk of Viral Infectious Diseases. 

PreVID will be available at select Apollo Pharmacy stores and Noble Plus Pharmacy stores across the country, as well as on online eCommerce platforms. Former Indian cricket team captain Mahendra Singh Dhoni has a stake in PreEmptive Meds, the Indian subsidiary of PMEDS. 

PreVID is a formulated nutraceutical delivering a burst of immuno-nutrients. Available in three different flavours, PreVID is a 100% vegan, sugar-free and gluten-free product. This product is completely developed and manufactured in India, suitable for anyone to consume over the age of eight. The fight against COVID-19 has proven that building a stronger immunity was the best response to win the battle against this (or any) virus. Thus, the need for strong immunity boosting and building nutraceuticals.

PreVID was developed by doctors based on widely published clinical evidence showing specific immunomodulatory and virucidal properties. PreEmptive Meds Pvt. Ltd has employed advanced sub-micron technology in addition to emulsification of organic curcumin and synthetically sourced Zinc, Vitamin C & D to formulate this product. A combination of precise and advanced food-science technologies ensures maximum potency and accelerated absorption.

“Indians have long taken to home remedies to fight viruses and build immunity. There is a huge opportunity to create an organized alternative to immunity building. PreVID is a high-science, evidence-based product that stands apart and provides much-needed micro-nutrient nourishment to our body’s first line of defence, i.e., our own immune system”, said Dr. Joe Fenn, Founder, PMEDS.

PMEDS- India, a subsidiary of PMEDS-US manufactures its branded nutraceuticals in India for the Indian market and for export from India. The deal between MS Dhoni and PMEDS-India was signed in 2019 and was facilitated by Aarka Sports Management, Pvt. Ltd.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

© Copyright 2021. Nuffoods Spectrum. All Rights Reserved.
Website Design & Developed By : SCI Knowledge Interlinks